摘要
肿瘤相关性缺血性卒中(cancer-associated ischemic stroke,CAIS)是一类临床表现复杂、复发风险高且预后不佳的疾病,其发病机制与凝血系统激活密切相关,但具体机制尚未完全阐明。目前,CAIS缺乏有效的筛查和治疗策略,导致其管理面临诸多挑战。因此,应重视多学科协作,加强对CAIS患者的早期识别与规范化管理,并呼吁开展更多相关临床研究。
Cancer-associated ischemic stroke(CAIS)is a disease with complex clinical manifestations,high risk of recurrence,and poor prognosis.Its pathogenesis is closely related to the activation of the coagulation system,but the specific mechanism has not been fully elucidated.At present,CAIS lacks effective screening and treatment strategies,leading to many challenges in its management.Therefore,multidisciplinary collaboration should be emphasized,early identification and standardized management of CAIS patients should be strengthened,and more relevant clinical research should be called for.
作者
徐炳东
林英泽
王舒泓
杨丹萍
徐安定
张玉生
XU Bingdong;LIN Yingze;WANG Shuhong;YANG Danping;XU Anding;ZHANG Yusheng(Department of Neurology,The First Affiliated Hospital of Jinan University,Guangzhou 510630,China)
出处
《中国卒中杂志》
北大核心
2025年第2期131-136,共6页
Chinese Journal of Stroke
基金
广东省自然科学基金面上项目(2020A1515011249)中央高校基本科研业务费专项资金资助(21620406)广州市科技计划项目(2023A03J0577)。
关键词
肿瘤相关性缺血性卒中
诊断
治疗
多学科协作
Cancer-associated ischemic stroke
Diagnosis
Treatment
Multidisciplinary collaboration
